Dr. Chan Wing Hung Anthony - Pathology
Specialist in Pathology
Highlights
- MCHK RegisteredVerified
- Specialist in PathologyBachelor of Medicine and Bachelor of Surgery (MBChB) · The Hong Kong College of Pathologists · Medical degree 2002
- InsuranceBeing compiled｜See details
About
Dr. Chan Wing Hung Anthony is a registered Pathology specialist in Hong Kong.
Education
Specialist in Pathology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)2002
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Chan Wing Hung Anthony? Claim page and update insurance →
FAQ
Is Dr. Chan Wing Hung Anthony any good?
Dr. Chan Wing Hung Anthony is a registered Pathology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Chan Wing Hung Anthony do?
Dr. Chan Wing Hung Anthony practises in Pathology.
Are you Dr. Chan Wing Hung Anthony? Claim this page to update and manage.
ClaimResearch and publications
48 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Histopathology-based assessment of the tumour microenvironment in gastrointestinal cancers: practical approaches to prognostication and treatment stratification.The journal of pathology. Clinical research · 2025
- Consensus statements on endoscopic ultrasound-guided tissue acquisition. Guidelines from the Asian Endoscopic Ultrasound Group.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2024
- PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer.Cancer research communications · 2024
- Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients.Gut · 2023
- Letter: repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma in ideal candidates.Alimentary pharmacology & therapeutics · 2023
- Recognising the clinically significant macrotrabecular massive variant of hepatocellular carcinoma.Singapore medical journal · 2023
- Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems.Journal of gastroenterology and hepatology · 2022
- Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.Hong Kong medical journal = Xianggang yi xue za zhi · 2022
- Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade.JHEP reports : innovation in hepatology · 2021
- Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma.Liver cancer · 2020
- Laparoscopic Hepatectomy (with or without Robotic Assistance) versus Radiofrequency Ablation as a Minimally Invasive Treatment for Very Early-Stage or Early-Stage Hepatocellular Carcinoma.Digestive surgery · 2020
- EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1.Journal of cellular and molecular medicine · 2020
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer